The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) closed at $5.66 in the last session, up 7.40% from day before closing price of $5.27. In other words, the price has increased by $7.40 from its previous closing price. On the day, 1.0 million shares were traded. AMLX stock price reached its highest trading level at $5.8088 during the session, while it also had its lowest trading level at $5.36.
Ratios:
We take a closer look at AMLX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.55 and its Current Ratio is at 4.55. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on November 18, 2024, Upgraded its rating to Outperform and sets its target price to $11 from $3 previously.
On October 23, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $4.20 to $10.
Mizuho Downgraded its Buy to Neutral on March 18, 2024, whereas the target price for the stock was revised from $32 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 30 ’24 when Klee Justin B. sold 18,589 shares for $3.20 per share. The transaction valued at 59,429 led to the insider holds 3,120,569 shares of the business.
Cohen Joshua B sold 18,589 shares of AMLX for $59,414 on Sep 30 ’24. The Co-Chief Executive Officer now owns 3,220,569 shares after completing the transaction at $3.20 per share. On Sep 30 ’24, another insider, Bedrosian Camille L, who serves as the Chief Medical Officer of the company, sold 11,442 shares for $3.20 each. As a result, the insider received 36,559 and left with 143,801 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMLX now has a Market Capitalization of 387981120 and an Enterprise Value of 156152880. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.01 while its Price-to-Book (P/B) ratio in mrq is 1.98. Its current Enterprise Value per Revenue stands at 0.795 whereas that against EBITDA is -0.629.
Stock Price History:
Over the past 52 weeks, AMLX has reached a high of $19.95, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is 27.38%, while the 200-Day Moving Average is calculated to be 38.49%.
Shares Statistics:
According to the various share statistics, AMLX traded on average about 1.43M shares per day over the past 3-months and 1858190 shares per day over the past 10 days. A total of 67.71M shares are outstanding, with a floating share count of 43.24M. Insiders hold about 36.92% of the company’s shares, while institutions hold 60.23% stake in the company. Shares short for AMLX as of 1730332800 were 1289340 with a Short Ratio of 0.90, compared to 1727654400 on 1279759. Therefore, it implies a Short% of Shares Outstanding of 1289340 and a Short% of Float of 2.07.
